Zika virus has long been known to the infectious disease community, but until the current outbreak, scant research had been conducted to understand the virus or how to combat it. The sudden explosion in infections—and the increasingly strong evidence that it can cause microcephaly in babies born to women infected while pregnant—has thrust Zika virus […]
Zika virus has long been known to the infectious disease community, but until the current outbreak, scant research had been conducted to understand the virus or how to combat it. The sudden explosion in infections—and the increasingly strong evidence that it can cause microcephaly in babies born to women infected while pregnant—has thrust Zika virus into the scientific spotlight.
This webinar, brought to you by ACS Infectious Diseases, will highlight the current scientific efforts being made to contain this outbreak and prevent future spread of Zika virus. Specifically, the focus of the webinar will be on the NIH response to the outbreak, vaccine development efforts from the pharmaceutical industry, and basic science research on Zika virus from an academic perspective.
During this free webinar you will learn:
· The NIH response to the Zika virus outbreak · The Zika virus vaccine development efforts from Sanofi Pasteur · The role of academic research in Zika virus response
Webinar Speakers
David M. Morens, M.D.
CAPT, United States Public Health Service, Senior Advisor to the Director
National Institute of Allergy and Infectious Diseases
National Institutes of Health Jon Heinrichs, Ph.D.
Associate Vice President,
Segment Head Sanofi Pasteur Pei-Yong Shi, Ph.D.
I.H. Kempner Professor of Human Genetics,
Department of Biochemistry & Molecular Biology,
University of Texas Medical Branch,
ACS Infectious Diseases Associate Editor
The webinar will be held Thursday, April 14 at 11 AM EDT.
Reserve your place at this webinar today!
